New Intel chip has possible device uses; TherOx advances oxygen device IDE study;

@FierceMedDev: Popular yesterday: Intuitive's surgical robots slammed in another study. Article | Follow @FierceMedDev

@DamianFierce: Dako got an FDA warning letter at the plant where it makes its Herceptin companion diagnostic. News | Follow @DamianFierce

@MarkHFierce: Baxter snatched up a tiny startup after closing a nearly $4B deal for Gambro. ICYMI yesterday | Follow @MarkHFierce

> Intel is launching a new line of processors, called Quark, that are designed, in part, for wearable medical devices. Story

> Syneron Medical ($ELOS) won FDA clearance and a CE mark for its new non-invasive body shaping tech. Item

> TherOx said it's completed enrollment in an IDE pilot study of a next-generation oxygen therapy device that helps salvage heart muscle after an attack. Item 

> Sweden's Aerocrine is launching its new portable, hand-held point-of-care device to measure inflamed airways. Item

> Fluke Biomedical, which provides medical device test and safety equipment, is launching its first iPad application. Item

> Colonoscopy device developer Invendo Medical has named a new COO and CTO, respectively; they cut their teeth at companies including Johnson & Johnson ($JNJ) and B. Braun. Item

> A scientist at Saudi Arabia's King Saud University has developed a device that helps surgeons determine the source of brain hemorrhaging. Story

@FierceBiotech: ICYMI yesterday: Is there a major R&D overhaul coming at Merck, or just more streamlining? Article | Follow @FierceBiotech

@JohnCFierce: ICYMI: FDA experts endorse new COPD blockbuster from GlaxoSmithKline, Theravance. Story | Follow @JohnCFierce

@EmilyMFierce: This week's issue of FierceBiotech Research: Parkinson's research gets boost; Drug combo tackles coronavirus. Check it out | Follow @EmilyMFierce

@Ry_McBride: Citivas scoops up $38M B round for inhaled Parkinsons drug. News | Follow @Ry_McBride

> OvaScience shares blitzed after FDA steps in to supervise lead product. News

> Merck laterals cancer drug to hungry AstraZeneca, focuses on star programs. Article

> Chimerix reports PhII failure for lead antiviral. Item

Pharma News

@FiercePharma: Italy's Recordati set to buy Spain's Laboratorios Casen Fleet for $122.4M. ICYMI yesterday | Follow @FiercePharma

@EricPFierce: KKR looks to buy stake in Gland Pharma as emotions are running high in India over loss of domestic cos. Report | Follow @EricPFierce

@CarlyHFierce: On why silence from Vivus is not golden. More via Seeking Alpha | Follow @CarlyHFierce

> South Africa writes IP policy making it harder to get drug patents. Story

> FDA ratchets up requirements on long-acting, extended-release opioids. Article

Drug Delivery News

@MichaelGFierce: Nanodiamonds deliver brain cancer drugs safely, UCLA team shows. Report | Follow @MichaelGFierce

> Activaero, Chiesi team up for cystic fibrosis drug-device research. News

> Low-cost microspheres take short-lived cancer drugs to brain. Article

> Oramed wins Chinese patent for oral core technology. Item

> CeQur closes $27M round to fund insulin delivery device. Story

Diagnostics News

> Nuclea snatches up Wilex AG Dx subsidiary. Story

> T2 jumps into pivotal trial for Candida assay. News

> NanoString gains FDA blessing for in vitro breast cancer assay. Report

> FDA cites Dx maker Dako for quality system violations. Article

> Study: Abbott blood test spots more female heart attack risks. Item

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.